Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombosis;Portal”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Large-scale testing (Phase 3)UnknownNCT02627053
What this trial is testing

Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

Who this might be right for
Portal Vein ThrombosisMesenteric Vein ThrombosisSplenic Vein Thrombosis
Università degli Studi dell'Insubria 100
Not applicableActive Not RecruitingNCT06248528
What this trial is testing

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Who this might be right for
Hepatocellular Carcinoma
Chen Xiaoping 1,076
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Not applicableStudy completedNCT05040347
What this trial is testing

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

Who this might be right for
Neutrophil Extracellular Trap FormationPortal Vein Tumor Thrombosis
The Affiliated Hospital of Qingdao University 68
Large-scale testing (Phase 3)UnknownNCT03468231
What this trial is testing

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BRAVE Study: QL1706 + Bevacizumab + SBRT for BCLC-C HCC With PVTT or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 46
Not applicableStudy completedNCT03068923
What this trial is testing

Thrombosis Outcomes in Pediatric Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
University of Texas Southwestern Medical Center 120
Large-scale testing (Phase 3)WithdrawnNCT03422419
What this trial is testing

TIPS or Anticoagulation in Portal Vein Thrombosis

Who this might be right for
Thrombosis Portal Vein
Insel Gruppe AG, University Hospital Bern
Not applicableUnknownNCT05789654
What this trial is testing

PADUA PREDICTION SCORE in Cirrhotic Patients

Who this might be right for
Portal Thrombosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 132
Not applicableUnknownNCT06117488
What this trial is testing

Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children

Who this might be right for
Portal Vein Thrombosis
Assiut University 30
Not applicableLooking for participantsNCT05124041
What this trial is testing

Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy

Who this might be right for
Acute on Chronic Liver FailureVariceal HemorrhageCirrhosis, Liver+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 140
Not applicableUnknownNCT04814251
What this trial is testing

Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study

Who this might be right for
Pancreatic Adenocarcinoma
Poitiers University Hospital 200
Large-scale testing (Phase 3)UnknownNCT03939845
What this trial is testing

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 180
Not applicableUnknownNCT03541057
What this trial is testing

Vienna Vascular Liver Disease Study

Who this might be right for
Vascular Liver DiseasePortal Vein ThrombosisBudd-Chiari Syndrome+4 more
Medical University of Vienna 200
Large-scale testing (Phase 3)UnknownNCT02853526
What this trial is testing

TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV

Who this might be right for
Portal Vein, Cavernous Transformation ofPortal Vein ThrombosisLiver Cirrhosis+1 more
Zaibo Jiang 100
Not applicableStudy completedNCT07252570
What this trial is testing

Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes

Who this might be right for
Biliary Tract NeoplasmsPancreatic NeoplasmPortal Hypertension+1 more
Centre Hospitalier Universitaire de Nice 63
Not applicableUnknownNCT03322280
What this trial is testing

TACE Combined With Iodine-125 Seeds Implantation for HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein OcclusionTumor Thrombus
Second Affiliated Hospital of Guangzhou Medical University 270
Post-approval studies (Phase 4)Looking for participantsNCT07132515
What this trial is testing

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Who this might be right for
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University 100
Not applicableStudy completedNCT01715779
What this trial is testing

Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

Who this might be right for
Hepatitis C
Novartis 22
Load More Results